Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLRB Cellectar Biosciences Inc.

盘前交易 11-18 05:10:51 EST

1.86

-0.15

-7.46%

最高2.04	最低1.83	成交量121.64万
今开2.01	昨收2.01	日振幅10.20%
总市值7,545万	流通市值5,743万	总股本4,057万
成交额232.13万	换手率3.94%	流通股本3,088万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences Inc.","latestPrice":1.86,"timestamp":1731704400000,"preClose":2.01,"halted":0,"volume":1216420,"delay":0,"floatShares":30877600,"shares":40566534,"eps":-2.335836,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.15,"latestTime":"11-18 05:10:51 EST","open":2.01,"high":2.035,"low":1.83,"amount":2321269.34939,"amplitude":0.10199,"askPrice":2.17,"askSize":100,"bidPrice":1.67,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.335836,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731940200000},"adr":0,"adjPreClose":1.86,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.93,"preClose":1.86,"latestTime":"19:07 EST","volume":3569,"amount":6827.57,"timestamp":1731715639001},"volumeRatio":4.678506072240923,"impliedVol":1.1017,"impliedVolPercentile":0.5248},"requestUrl":"/m/hq/s/CLRB","defaultTab":"news","newsList":[{"id":"2483379322","title":"Cellectar Biosciences Inc   预计每股亏损37美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483379322","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483379322?lang=zh_cn&edition=full","pubTime":"2024-11-15 21:54","pubTimestamp":1731678850,"startTime":"0","endTime":"0","summary":"   * Cellectar Biosciences Inc    将于11月18日公布截至2024年9月30日的财报，预计该公司的季度收入将保持不变。*    * LSEG 的分析师平均预计 Cellectar Biosciences Inc 每股亏损 37 美分。* 华尔街对 Cellectar Biosciences Inc 的 12 个月目标价中位数为 13.50 美元，高于其最新收盘价 2.01 美元。11月15日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cellectar Biosciences Inc   预计每股亏损37美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB"],"gpt_icon":0},{"id":"2483723332","title":"Cellectar Biosciences, Inc.盘中异动 快速跳水5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483723332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483723332?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:53","pubTimestamp":1731617628,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时53分，Cellectar Biosciences, Inc.股票出现波动，股价快速下挫5.21%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为4952.18%、3493.33%、403.47%，振幅较大的相关个股有Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为249.67%、218.18%、188.46%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045348a2388f82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045348a2388f82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2479288056","title":"Cellectar Biosciences Inc    预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479288056","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479288056?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:46","pubTimestamp":1730209562,"startTime":"0","endTime":"0","summary":"   * Cellectar Biosciences Inc    预计在10月31日发布业绩报告时，季度营收将不会有变化(预计)，截至2024年6月30日。*    * LSEG分析师对Cellectar Biosciences Inc的平均预期是每股亏损34美分。* 华尔街对 Cellectar Biosciences Inc 的 12 个月目标价中位数为 13.50 美元，高于其最新收盘价 2.05 美元。10月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cellectar Biosciences Inc    预计每股亏损 34 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB"],"gpt_icon":0},{"id":"2474820391","title":"Cellectar Biosciences, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474820391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474820391?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:07","pubTimestamp":1728500850,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时07分，Cellectar Biosciences, Inc.股票出现波动，股价大幅跳水5.08%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Nutriband Inc C/Wts 、Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为726.64%、573.06%、250.04%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Inhibikase Therapeutics, Inc.，振幅分别为108.00%、73.66%、64.70%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003073198e3b862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003073198e3b862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","CLRB"],"gpt_icon":0},{"id":"2473487705","title":"Cellectar Biosciences, Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473487705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473487705?lang=zh_cn&edition=full","pubTime":"2024-10-08 03:04","pubTimestamp":1728327885,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日03时04分，Cellectar Biosciences, Inc.股票出现异动，股价急速跳水5.00%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Celularity Inc C/Wts 16/07/2026 涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1663.82%、94.85%、60.66%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lakeshore Biopharma Co., Ltd，振幅分别为107.82%、39.46%、38.72%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008030445a1deb4cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008030445a1deb4cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2471238314","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.39%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471238314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471238314?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:41","pubTimestamp":1727703676,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时41分，Cellectar Biosciences, Inc.股票出现波动，股价快速拉升5.39%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Prime Medicine, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为45.59%、18.93%、17.73%，振幅较大的相关个股有Plus Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Gain Therapeutics, Inc.，振幅分别为28.10%、19.84%、18.09%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302141169719d98c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302141169719d98c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2470806740","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470806740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470806740?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:51","pubTimestamp":1727448698,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时51分，Cellectar Biosciences, Inc.股票出现异动，股价大幅上涨5.24%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3753.45%、193.10%、116.74%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为152.50%、60.69%、51.69%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927225139ab668647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927225139ab668647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2459706891","title":"Cellectar Biosciences, Inc.盘中异动 早盘快速拉升5.20%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459706891","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459706891?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:09","pubTimestamp":1723644546,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时09分，Cellectar Biosciences, Inc.股票出现波动，股价大幅上涨5.20%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Conduit Pharmaceuticals Inc.、Newamsterdam Pharma Co Nv C/Wts 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为82.42%、65.21%、48.33%，振幅较大的相关个股有Genprex, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为58.52%、48.32%、44.00%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081422090798e34f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081422090798e34f05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2459801909","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨8.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459801909","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459801909?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:32","pubTimestamp":1723555922,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时32分，Cellectar Biosciences, Inc.股票出现波动，股价大幅拉升8.06%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、冠科美博、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Genprex, Inc.、冠科美博、Psyence Biomedical Ltd.较为活跃，换手率分别为106.97%、66.16%、18.33%，振幅较大的相关个股有冠科美博、Jaguar Health, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为21.54%、15.12%、10.94%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132029f278daf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132029f278daf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2458488465","title":"Cellectar Biosciences Inc    预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458488465","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458488465?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:54","pubTimestamp":1723229682,"startTime":"0","endTime":"0","summary":"   * Cellectar Biosciences Inc    将于8月13日公布截至2024年6月30日的财报，预计该公司的季度收入将保持不变。*    * LSEG分析师对Cellectar Biosciences Inc的平均预期是每股亏损36美分。* 华尔街对 Cellectar Biosciences Inc 的 12 个月目标价中位数为 13.50 美元，高于其最新收盘价 1.93 美元。8月9日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cellectar Biosciences Inc    预计每股亏损 36 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB"],"gpt_icon":0},{"id":"2457163778","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌6.57%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457163778","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457163778?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:30","pubTimestamp":1722864623,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时30分，Cellectar Biosciences, Inc.股票出现波动，股价快速跳水6.57%。截至发稿，该股报1.85美元/股，成交量16.4945万股，换手率0.46%，振幅0.51%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.55%。其相关个股中，Okyo Pharma Ltd Com Npv 、Briacell Therapeutics Corp C/Wts 24/02/2025、Alterity Therapeutics Limited涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为968.07%、30.43%、13.47%，振幅较大的相关个股有Cel-Sci Corporation、Onconetix, Inc.、Stoke Therapeutics, Inc.，振幅分别为8.70%、5.23%、5.08%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213023941fe2bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213023941fe2bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2456468831","title":"Cellectar Biosciences, Inc.盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456468831","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456468831?lang=zh_cn&edition=full","pubTime":"2024-08-02 02:46","pubTimestamp":1722537967,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日02时46分，Cellectar Biosciences, Inc.股票出现异动，股价大幅下挫5.10%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为2860.66%、376.90%、218.52%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Renovaro Inc.、Virax Biolabs Group Limited，振幅分别为59.30%、57.88%、43.37%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802024608af9567a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802024608af9567a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2455666106","title":"Cellectar Biosciences, Inc.盘中异动 早盘大幅下跌5.67%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455666106","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455666106?lang=zh_cn&edition=full","pubTime":"2024-07-29 22:33","pubTimestamp":1722263580,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日22时33分，Cellectar Biosciences, Inc.股票出现波动，股价急速下跌5.67%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Lipella Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1854.48%、632.30%、199.00%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为143.50%、75.11%、57.78%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729223300aefbfbdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729223300aefbfbdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2454832073","title":"Cellectar Biosciences, Inc.盘中异动 快速下挫5.28%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454832073","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454832073?lang=zh_cn&edition=full","pubTime":"2024-07-27 00:26","pubTimestamp":1722011175,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日00时26分，Cellectar Biosciences, Inc.股票出现波动，股价大幅跳水5.28%。截至发稿，该股报2.24美元/股，成交量35.5823万股，换手率0.99%，振幅8.89%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Windtree Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为5557.49%、204.16%、143.69%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Windtree Therapeutics, Inc.、Cel-Sci Corporation，振幅分别为182.50%、98.48%、91.73%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727002615aefbb53b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727002615aefbb53b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2453882914","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌5.28%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453882914","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453882914?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:30","pubTimestamp":1721835032,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时30分，Cellectar Biosciences, Inc.股票出现异动，股价急速下挫5.28%。截至发稿，该股报2.33美元/股，成交量56.1713万股，换手率1.57%，振幅8.54%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为7819.82%、1228.81%、633.88%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为191.54%、99.60%、75.86%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724233032941fa316&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724233032941fa316&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139","BK4007","BK4539","DRMA"],"gpt_icon":0},{"id":"2453793971","title":"Cellectar Biosciences, Inc.盘中异动 早盘大幅上涨10.71%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453793971","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453793971?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:32","pubTimestamp":1721655149,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时32分，Cellectar Biosciences, Inc.股票出现异动，股价快速上涨10.71%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Aileron Therapeutics, Inc.、Enveric Biosciences, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为93.58%、77.83%、16.26%，振幅较大的相关个股有Aileron Therapeutics, Inc.、Exicure, Inc.、Nucana Plc，振幅分别为14.23%、13.38%、9.06%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722213229954fd373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722213229954fd373&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2452491211","title":"Cellectar Biosciences, Inc.盘中异动 临近午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452491211","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452491211?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:58","pubTimestamp":1721145514,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时58分，Cellectar Biosciences, Inc.股票出现异动，股价快速拉升5.08%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Silo Pharma, Inc.、Nutriband Inc C/Wts 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3166.95%、1262.12%、378.23%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.，振幅分别为79.41%、61.68%、57.94%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162358349681d3c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162358349681d3c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2450364370","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.11%报2.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450364370","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450364370?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:05","pubTimestamp":1720710329,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日23时05分，Cellectar Biosciences, Inc.股票出现异动，股价急速上涨5.11%。截至发稿，该股报2.47美元/股，成交量11.0283万股，换手率0.31%，振幅5.32%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Okyo Pharma Ltd Com Npv 涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为602.42%、523.29%、390.97%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited，振幅分别为149.07%、88.60%、82.31%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112305299681c0d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112305299681c0d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2449492706","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.44%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449492706","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449492706?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:02","pubTimestamp":1720447330,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时02分，Cellectar Biosciences, Inc.股票出现异动，股价大幅拉升5.44%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Morphic Holding, Inc.、Virpax Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为817.27%、161.43%、133.76%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为65.74%、36.60%、34.48%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082202119681aa9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082202119681aa9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","VRPX","BK4007","BK4139"],"gpt_icon":0},{"id":"2449997312","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449997312","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449997312?lang=zh_cn&edition=full","pubTime":"2024-07-05 23:16","pubTimestamp":1720192571,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日23时16分，Cellectar Biosciences, Inc.股票出现波动，股价快速跳水5.26%。截至发稿，该股报2.34美元/股，成交量8.5502万股，换手率0.24%，振幅4.45%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Annovis Bio, Inc.涨幅较大，Kintara Therapeutics, Inc.、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.较为活跃，换手率分别为11593.58%、2120.01%、92.28%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.，振幅分别为151.52%、61.48%、46.66%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052316119681a2e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052316119681a2e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139","CLRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectar.com","stockEarnings":[{"period":"1week","weight":-0.1226},{"period":"1month","weight":-0.1058},{"period":"3month","weight":-0.0837},{"period":"6month","weight":-0.4364},{"period":"1year","weight":-0.07},{"period":"ytd","weight":-0.3285}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectar Biosciences, Inc.以前名为Novelos Therapeutics, Inc.于1996年6月成立于特拉华州。2014年2月11日，公司更名为现在的名字。它是一家生物制药公司，开发用于治疗肿瘤成像化合物。该公司的癌症靶向技术允许选择性递送的多种剂对癌症细胞，包括癌症干细胞。该公司目前正在开发三种专利的候选产品：I-124-CLR1404 是一种小分子，广谱，肿瘤的靶向性的正电子发射断层扫描（PET）显像剂，该公司认为其必须在范围广泛的癌症肿瘤和转移的选择性检测的第一种可能。I-131-CLR1404是一种小分子，广谱，癌靶向分子放射治疗的直接和选择性地提供细胞毒性（细胞杀伤）辐射到癌细胞和癌干细胞。CLR1502是一种临床前，小分子，肿瘤靶向，非放射性的光学成像术中肿瘤边缘照明和非侵入性的肿瘤成像剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.027916},{"month":2,"riseRate":0.6,"avgChangeRate":0.012926},{"month":3,"riseRate":0.5,"avgChangeRate":-0.02847},{"month":4,"riseRate":0.2,"avgChangeRate":-0.095326},{"month":5,"riseRate":0.3,"avgChangeRate":0.04729},{"month":6,"riseRate":0.4,"avgChangeRate":-0.071836},{"month":7,"riseRate":0.3,"avgChangeRate":-0.074001},{"month":8,"riseRate":0.4,"avgChangeRate":-0.015388},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.040633},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.138405},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.059685},{"month":12,"riseRate":0.4,"avgChangeRate":0.02288}],"exchange":"NASDAQ","name":"Cellectar Biosciences Inc.","nameEN":"Cellectar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectar Biosciences Inc.,CLRB,Cellectar Biosciences Inc.股票,Cellectar Biosciences Inc.股票老虎,Cellectar Biosciences Inc.股票老虎国际,Cellectar Biosciences Inc.行情,Cellectar Biosciences Inc.股票行情,Cellectar Biosciences Inc.股价,Cellectar Biosciences Inc.股市,Cellectar Biosciences Inc.股票价格,Cellectar Biosciences Inc.股票交易,Cellectar Biosciences Inc.股票购买,Cellectar Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况